[3-[2-[4-[3-[1-(4-ISOBUTYLPHENYL)ETHYL]-5-THIOXO-1H-1,2,4-TRIAZOL-4-YL]-2-[(3-NITROOXYPROPANOYLAMINO)CARBAMOYL]BENZOYL]HYDRAZINO]-3-OXO-PROPYL]NITRATE


Molecule Category	Free-form
Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	QHRIXQUWDNJTCI-UHFFFAOYSA-N
Smiles	CC(C)Cc1ccc(cc1)C(C)C2=NNC(=S)N2c3ccc(C(=O)NNC(=O)CCO[N+](=O)[O-])c(c3)C(=O)NNC(=O)CCO[N+](=O)[O-]
InChI	InChI=1S/C28H33N9O10S/c1-16(2)14-18-4-6-19(7-5-18)17(3)25-31-34-28(48)35(25)20-8-9-21(26(40)32-29-23(38)10-12-46-36(42)43)22(15-20)27(41)33-30-24(39)11-13-47-37(44)45/h4-9,15-17H,10-14H2,1-3H3,(H,29,38)(H,30,39)(H,32,40)(H,33,41)(H,34,48)

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C28H33N9O10S
Molecular Weight	687.68
AlogP	6.55
Hydrogen Bond Acceptor	12.0
Hydrogen Bond Donor	5.0
Number of Rotational Bond	17.0
Polar Surface Area	286.21
Molecular species	ACID
Aromatic Rings	2.0
Heavy Atoms	48.0

Assay Description	Organism	Bioactivity
Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as carrageenan-induced paw edema at 66.69 mg/kg, po administered 1 hr prior to carrageenan-challenge measured at 1 hr relative to control	Rattus norvegicus	27.87 %
Analgesic activity in Mus musculus (mouse) assessed as inhibition of acetic acid-induced writhing at 49.46 mg/kg, po measured after 5 min for 15 min relative to control	Mus musculus	48.56 %
Induction of nitric oxide release at 10'-4 M after 1 hr by Griess method relative to control	None	0.57 %
Vasorelaxant activity in normotensive Rattus norvegicus Wistar albino (rat) aorta assessed as inhibition of norepinephrine-induced contraction	Rattus norvegicus	34.88 ug.mL-1
Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as carrageenan-induced paw edema at 66.69 mg/kg, po administered 1 hr prior to carrageenan-challenge measured at 3 hr relative to control	Rattus norvegicus	31.93 %
Anti-inflammatory activity in Rattus norvegicus Wistar albino (rat) assessed as carrageenan-induced paw edema at 66.69 mg/kg, po administered 1 hr prior to carrageenan-challenge measured at 2 hr relative to control	Rattus norvegicus	29.94 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2262570
PubChem	76323076

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).